Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
Product Unit Size | Cost | Quantity | Stock |
---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
Cas No. | 950736-05-7 |
---|---|
Purity | ≥98% |
Formula | C29H24F3N5O |
Formula Wt. | 515.54 |
IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
Solubility | DMSO: ≥ 53 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
β1/2-adrenergic agonist.
Polyphenolic compound present in black tea.
SIRT1/2 inhibitor, indirect p53 activator.
Light-emitting luciferin analog found in aquati...
Semi-synthetic analog of taxol; microtubule dep...
mTOR inhibitor.
Allylbenzene found in spices and umbelliferous ...
Endogenous bombesin-like peptide, involved in f...
5-HT3 antagonist.
Calcium channel blocker.
β-lactam cephalosporin; penicillin binding pro...
Endogenous neuropeptide, involved in energy hom...
p110α PI3K and mTOR inhibitor.
Antineoplastic immunomodulator.
Serum response factor inhibitor and MRTF-A bind...
Protease inhibitor.
Retinol (vitamin A) analog, binds RBP4; Des1 in...
Sirtuin inhibitor and iron chelator.
Glycoprotein IIb/IIIa inhibitor.
Nonoxynol surfactant.